ArticleFrontiers in pharmacology2026

Empagliflozin-pirfenidone dual therapy improves cardiac function and structure in a preclinical two-hit HFpEF model.

Yuexin Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.